diltiazem has been researched along with esmolol in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (31.82) | 18.2507 |
2000's | 9 (40.91) | 29.6817 |
2010's | 6 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Boylan, JF; Ivanov, J; Mickle, DA; O'Leary, G; Teasdale, SJ; Weisel, RD | 1 |
Paul, SC | 1 |
Herbert, ME; Rutz, F; Votey, SR | 1 |
Bolar-Softich, KL; Elam, K | 1 |
Balser, JR; Breslow, MJ; Campbell, K; Clarke, AW; Dorman, T; Huang, W; Lipsett, P; Martinez, EA; Perdue, PW; Rosenfeld, BA; Tomaselli, GF; Winters, BD | 1 |
Bhan, A; Chauhan, S; Rao, BH; Saxena, N; Singh, RS | 1 |
Gupta, A; Lokhandwala, Y; Naik, A; Vora, A | 1 |
Hilleman, DE; Mohiuddin, SM; Mooss, AN; Reyes, AP; Scott, W; Seyedroudbari, A; Sugimoto, JT; Wurdeman, RL | 1 |
Bares, AC; Hsu, W; Knight, BP; Morady, F; Oral, H; Pelosi, F; Sticherling, C; Strickberger, SA; Tada, H | 1 |
Hilleman, DE; Mooss, AN; Packard, KA; Reyes, AP | 1 |
Bauer, A; Donahue, JK; Heldman, AW; McDonald, AD; Miller, JM; Nasir, K; Peller, L; Rade, JJ | 1 |
Ahmad, S; Ahmed, S; Hassan, S; Kakish, E; Kamalakannan, D; Khoury, R; Kronick, SL; Maria, V; Morady, F; Oral, H; Pires, LA; Slim, AM | 1 |
Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA | 1 |
Derumeaux, G; Ferrera, R; Hadour, G; Henry, JP; Mulder, P; Ovize, M; Richard, V; Tamion, F; Thuillez, C | 1 |
Shen, SL; Zhao, YC | 1 |
Brad Hall, A; Harvey, S; Wilson, K | 1 |
Brubaker, S; Koyfman, A; Long, B | 1 |
3 review(s) available for diltiazem and esmolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dilemmas in the acute pharmacologic treatment of uncontrolled atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diltiazem; Emergency Medical Services; Humans; Propanolamines | 1997 |
Alternative Treatment Options for Atrioventricular-Nodal-Reentry Tachycardia: An Emergency Medicine Review.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Diltiazem; Electric Countershock; Electrocardiography; Emergency Medicine; Emergency Service, Hospital; Female; Humans; Male; Metoprolol; Propanolamines; Propranolol; Review Literature as Topic; Tachycardia, Atrioventricular Nodal Reentry; Vagus Nerve Stimulation; Verapamil | 2018 |
8 trial(s) available for diltiazem and esmolol
Article | Year |
---|---|
A comparison of diltiazem, esmolol, nifedipine and nitroprusside therapy of post-CABG hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Coronary Artery Bypass; Coronary Circulation; Diltiazem; Energy Metabolism; Ferricyanides; Humans; Hypertension; Infusions, Intravenous; Myocardium; Nifedipine; Nitroprusside; Postoperative Complications; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Critical Care; Diltiazem; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Injections, Intravenous; Male; Postoperative Complications; Propanolamines; Tachycardia, Supraventricular; Time Factors | 1998 |
A comparison of esmolol & diltiazem for heart rate control during coronary revascularisation on beating heart.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Coronary Disease; Diltiazem; Heart Rate; Hemodynamics; Humans; Monitoring, Intraoperative; Myocardial Revascularization; Propanolamines | 1999 |
Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cross-Over Studies; Diltiazem; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Prospective Studies; Tachycardia, Supraventricular; Treatment Outcome | 1999 |
Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Cost-Benefit Analysis; Diltiazem; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Probability; Prognosis; Propanolamines; Reference Values; Survival Rate; Treatment Outcome | 2000 |
Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation.
Topics: Adult; Atrial Fibrillation; Blood Pressure; Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Middle Aged; Propanolamines; Time Factors | 2002 |
Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Calcium Channel Blockers; Diltiazem; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Prospective Studies; Treatment Outcome | 2007 |
[A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anesthesia; Atrial Fibrillation; Child; Diltiazem; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Treatment Outcome; Young Adult | 2010 |
11 other study(ies) available for diltiazem and esmolol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
New pharmacologic agents for emergency management of supraventricular tachydysrhythmias.
Topics: Adenosine; Adrenergic beta-Antagonists; Clinical Protocols; Diltiazem; Emergencies; Humans; Propanolamines; Tachycardia, Supraventricular | 1993 |
New treatment of atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diltiazem; Drug Therapy, Combination; Emergency Medicine; Heart Failure; Humans; Propanolamines; Verapamil | 1996 |
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Female; Humans; Male; Medical Records; Postoperative Complications; Propanolamines; Retrospective Studies; Treatment Outcome | 2003 |
Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation.
Topics: Acute Disease; Adenoviridae; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Artificial; Digoxin; Diltiazem; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Failure; Heart Rate; Propanolamines; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Stroke Volume; Sus scrofa; Ultrasonography | 2004 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Blockers; Diltiazem; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Organ Size; Prednisone; Propanolamines; Propranolol; Radiography; Thymus Gland; Thymus Hyperplasia; Thyroidectomy; Thyrotoxicosis; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine; Young Adult | 2010 |
Brain death provokes very acute alteration in myocardial morphology detected by echocardiography: preventive effect of beta-blockers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain Death; Calcium Channel Blockers; Diltiazem; Echocardiography; Edema; Heart Rate; Male; Myocardium; Prazosin; Propanolamines; Rats; Rats, Wistar | 2011 |
Diltiazem versus esmolol for acute rate control in the emergency department.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Arrhythmias, Cardiac; Diltiazem; Emergency Service, Hospital; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Retrospective Studies; Treatment Outcome | 2017 |